|
|
 |
|
THRX: Theravance Inc - Stock News |
Enter Ticker:
|
|
| Nov 24, 2009 |
Theravance Down 5.2% Since SmarTrend's Sell Recommendation |
| Nov 05, 2009 |
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM)(telavancin) in the United States |
| Nov 03, 2009 |
Theravance to Present at the 18th Annual Credit Suisse Health CareConference |
| Nov 03, 2009 |
Theravance Inc awards option for 1,500 shares to new employee |
| Nov 02, 2009 |
Theravance Announces New Employment Inducement Award |
| Oct 28, 2009 |
Astellas and Theravance Announce Submission of Telavancin MAA for theTreatment of Nosocomial Pneumonia and Complicated Skin and SoftTissue Infections in Europe |
| Oct 27, 2009 |
Zacks Analyst Blog Highlights: Theravance, ViroPharma, Pfizer, Johnson & Johnson and Forest Laboratories |
| Oct 23, 2009 |
BUYINS.NET: WFMI, AEE, CPX, CMO, RNWK, THRX Expected To Be Lower Leading Up To Next Earnings Releases |
| Oct 22, 2009 |
Theravance Earns $20 Million Milestone Under Telavancin CollaborationAgreement |
| Oct 19, 2009 |
Theravance to Report Third Quarter 2009 Financial Results on October27, 2009 |
| Oct 16, 2009 |
BUYINS.NET: Short Sale Recap. Highest % Of Daily Trading Volume Short All Exchanges Combined For Thursday |
| Oct 01, 2009 |
Theravance Announces New Employment Inducement Award |
| Oct 01, 2009 |
THRX: Health Canada Approval of VIBATIV(TM) for Skin Infections |
| Oct 01, 2009 |
Astellas and Theravance Announce Approval of VIBATIV(TM) (telavancin)in Canada for the Treatment of Complicated Skin and Skin StructureInfections |
| Sep 18, 2009 |
BUYINS.NET: 50.14% Of All NASDAQ Trading Thursday Was Short Selling. TIXC, NXXI, ALVR, PLCM, THRX, EPCT Highest % Of Daily Trading Volume Short |
| |
| ZACKS COMMENTARY FOR THRX |
|
|
|
Sponsored Links 
-0.27